argenx SE (ARGX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ARGX Stock Forecast


argenx SE stock forecast is as follows: an average price target of $558.78 (represents a -10.74% downside from ARGX’s last price of $626.03) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.

ARGX Price Target


The average price target for argenx SE (ARGX) is $558.78 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $715.00 to $500.00. This represents a potential -10.74% downside from ARGX's last price of $626.03.

ARGX Analyst Ratings


Buy

According to 21 Wall Street analysts, argenx SE's rating consensus is 'Buy'. The analyst rating breakdown for ARGX stock is 1 'Strong Buy' (4.76%), 18 'Buy' (85.71%), 2 'Hold' (9.52%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

argenx SE Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024George FarmerScotiabank$715.00$602.4718.68%14.21%
Oct 10, 2024Danielle BrillRaymond James$605.00$520.5216.23%-3.36%
Jul 29, 2024Joel BeattyRobert W. Baird$515.00$495.923.85%-17.74%
Jul 26, 2024Douglas TsaoH.C. Wainwright$533.00$492.068.32%-14.86%
Jul 23, 2024Leland GershellOppenheimer$546.00$461.0118.44%-12.78%
Jul 22, 2024Joon LeeTruist Financial$540.00$461.0117.13%-13.74%
Jul 12, 2024Gavin Clark-GartnerEvercore ISI$533.00$461.7215.44%-14.86%
Jun 26, 2024Douglas TsaoH.C. Wainwright$490.00$451.558.52%-21.73%
Jun 24, 2024Joon LeeTruist Financial$480.00$441.158.81%-23.33%
Jun 24, 2024George FarmerScotiabank$416.00$437.96-5.01%-33.55%
Jun 24, 2024Derek ArchilaWells Fargo$542.00$394.4737.40%-13.42%
Jun 24, 2024Alex ThompsonStifel Nicolaus$500.00$436.7914.47%-20.13%
May 10, 2024Douglas TsaoH.C. Wainwright$448.00$380.8917.62%-28.44%
May 09, 2024Derek ArchiliaStifel Nicolaus$485.00$382.5526.78%-22.53%
Jan 10, 2023H.C. Wainwright$480.00$372.9628.70%-23.33%
Dec 31, 2022Stifel StifelStifel Nicolaus$478.00$378.8326.18%-23.65%
Jan 20, 2022Daan VandenberkKepler Capital$326.27$281.4815.91%-47.88%
Jan 07, 2022David NierengartenWedbush$382.00$312.5822.21%-38.98%
Jan 04, 2022James GordonJ.P. Morgan$400.00$344.0016.28%-36.11%
Dec 20, 2021Tazeen AhmadBank of America Securities$383.00$337.5113.48%-38.82%
Oct 28, 2021Yatin SunejaGuggenheim$330.00$280.8317.51%-47.29%
Oct 06, 2021Akash TewariJefferies$362.00$293.3023.42%-42.18%
Jun 18, 2021Laura SutcliffeUBS$390.00$318.1622.58%-37.70%

The latest argenx SE stock forecast, released on Nov 05, 2024 by George Farmer from Scotiabank, set a price target of $715.00, which represents a 18.68% increase from the stock price at the time of the forecast ($602.47), and a 14.21% increase from ARGX last price ($626.03).

argenx SE Price Target by Period


1M3M12M
# Anlaysts-214
Avg Price Target-$660.00$524.86
Last Closing Price$626.03$626.03$626.03
Upside/Downside-100.00%5.43%-16.16%

In the current month, the average price target of argenx SE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to argenx SE's last price of $626.03. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Dec 09, 2024Piper SandlerOverweightOverweightHold
Nov 22, 2024JefferiesBuyBuyHold
Nov 11, 2024Wolfe ResearchOutperformUpgrade
Nov 05, 2024ScotiabankSector PerformOutperformUpgrade
Nov 01, 2024Leerink PartnersOutperformOutperformHold
Nov 01, 2024William BlairOutperformOutperformUpgrade
Oct 17, 2024WedbushUnderperformUnderperformHold
Oct 17, 2024Wells FargoBuyBuyHold
Oct 17, 2024CitigroupBuyBuyHold
Oct 04, 2024Deutsche BankBuyHoldDowngrade
Sep 26, 2024Wells FargoBuyBuyHold
Sep 25, 2024Piper SandlerOverweightOverweightHold
Aug 29, 2024UBSNeutralNeutralHold
Aug 23, 2024Wells FargoBuyBuyHold
Aug 06, 2024BarclaysEqual-WeightOverweightUpgrade
Jul 29, 2024Wells FargoBuyBuyHold
Jul 26, 2024WedbushOutperformOutperformHold
Jul 26, 2024OppenheimerOutperformOutperformHold
Jul 26, 2024GuggenheimBuyBuyHold
Jul 26, 2024Wells FargoOverweightOverweightHold
Jul 25, 2024Deutsche BankBuyUpgrade
Jul 23, 2024OppenheimerOutperformUpgrade
Jul 17, 2024H.C. WainwrightBuyBuyHold
Jul 12, 2024Evercore ISIOutperformOutperformHold
Jun 25, 2024BarclaysEqual-WeightEqual-WeightHold
Jun 24, 2024CitigroupBuyBuyHold
Jun 24, 2024ScotiabankSector PerformSector PerformHold
Jun 24, 2024Cowen & Co.BuyBuyHold
Jun 24, 2024Wells FargoOverweightOverweightHold
Jun 17, 2024Piper SandlerOverweightOverweightHold
Jun 14, 2024H.C. WainwrightBuyBuyHold
May 28, 2024BarclaysEqual-WeightEqual-WeightHold
May 10, 2024Wells FargoMarket OutperformMarket OutperformHold
May 10, 2024H.C. WainwrightBuyBuyHold
Apr 18, 2024Wells FargoSector PerformSector PerformHold
Mar 26, 2024Wells FargoMarket OutperformMarket OutperformHold
Dec 21, 2023Wells FargoOverweightOverweightHold
Nov 30, 2023Morgan StanleyOverweightOverweightHold
Nov 29, 2023Raymond JamesStrong BuyStrong BuyHold
Jan 10, 2023Telsey AdvisoryBuyBuyHold
Dec 15, 2022Goldman SachsBuyBuyHold
Dec 07, 2022William BlairOutperformInitialise
Oct 28, 2022SVB LeerinkOutperformOutperformHold
Jul 25, 2022Piper SandlerOverweightOverweightHold
May 03, 2022Morgan StanleyOverweightUpgrade

argenx SE's last stock rating was published by Piper Sandler on Dec 09, 2024. The company gave ARGX a "Overweight" rating, the same as its previous rate.

argenx SE Financial Forecast


argenx SE Revenue Forecast

Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Mar 23Dec 22Mar 22Mar 21Sep 20Mar 19Mar 18Jun 17
Revenue-------$219.14M$174.16M$23.41M$158.16M$11.47M$40.94M$6.87M$18.56M
Avg Forecast$649.73M$624.45M$484.13M$409.26M$376.23M$346.95M$292.61M$22.24M$15.01M$23.36M$210.64M$9.37M$73.12M$5.08M$29.70M
High Forecast$723.69M$685.46M$530.89M$448.80M$412.58M$354.65M$320.88M$26.68M$18.01M$28.03M$252.77M$11.24M$87.74M$6.10M$35.64M
Low Forecast$593.42M$583.98M$430.55M$363.97M$334.59M$316.34M$260.23M$17.79M$12.00M$18.69M$168.51M$7.50M$58.49M$4.06M$23.76M
# Analysts8157661210161571616121817
Surprise %-------9.85%11.61%1.00%0.75%1.22%0.56%1.35%0.63%

argenx SE's average Quarter revenue forecast for Sep 23 based on 10 analysts is $292.61M, with a low forecast of $260.23M, and a high forecast of $320.88M. ARGX's average Quarter revenue forecast represents a 33.53% increase compared to the company's last Quarter revenue of $219.14M (Mar 23).

argenx SE EBITDA Forecast

Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Mar 23Dec 22Mar 22Mar 21Sep 20Mar 19Mar 18Jun 17
# Analysts8157661210161571616121817
EBITDA-------$-87.16M$-100.51M$-221.91M$-29.25M$-157.21M$7.78M$-21.77M$-390.75K
Avg Forecast$-494.89M$-475.63M$-368.75M$-311.73M$-205.90M$-264.27M$-222.88M$-217.62M$-61.43M$-228.63M$-38.96M$-85.62M$13.90M$-10.73M$-625.20K
High Forecast$-452.00M$-444.81M$-327.94M$-277.23M$-164.72M$-240.95M$-198.21M$-174.10M$-49.15M$-182.90M$-31.16M$-68.50M$16.68M$-8.59M$-500.16K
Low Forecast$-551.23M$-522.11M$-404.38M$-341.85M$-247.08M$-270.13M$-244.41M$-261.15M$-73.72M$-274.36M$-46.75M$-102.75M$11.12M$-12.88M$-750.24K
Surprise %-------0.40%1.64%0.97%0.75%1.84%0.56%2.03%0.63%

16 analysts predict ARGX's average Quarter EBITDA for Sep 20 to be $-85.62M, with a high of $-68.50M and a low of $-102.75M. This is -1200.38% lower than argenx SE's previous annual EBITDA (Mar 19) of $7.78M.

argenx SE Net Income Forecast

Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Mar 23Dec 22Mar 22Mar 21Sep 20Mar 19Mar 18Jun 17
# Analysts8157661210161571616121817
Net Income-------$-28.87M$-38.61M$-227.19M$-40.43M$-157.66M$7.58M$-26.10M$-387.55K
Avg Forecast$114.99M$74.59M$5.94M$-55.15M$-204.16M$-74.13M$-87.12M$-215.79M$-61.74M$-226.70M$-53.85M$-85.87M$13.54M$-10.73M$-620.07K
High Forecast$170.94M$146.69M$6.68M$-47.21M$-163.33M$-38.57M$-74.59M$-172.63M$-49.39M$-181.36M$-43.08M$-68.70M$16.24M$-8.59M$-496.06K
Low Forecast$4.35M$-2.49M$5.08M$-62.08M$-245.00M$-156.69M$-98.07M$-258.95M$-74.08M$-272.04M$-64.62M$-103.05M$10.83M$-12.88M$-744.09K
Surprise %-------0.13%0.63%1.00%0.75%1.84%0.56%2.43%0.63%

argenx SE's average Quarter net income forecast for Sep 20 is $-85.87M, with a range of $-103.05M to $-68.70M. ARGX's average Quarter net income forecast represents a -1232.99% decrease compared to the company's last Quarter net income of $7.58M (Mar 19).

argenx SE SG&A Forecast

Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Mar 23Dec 22Mar 22Mar 21Sep 20Mar 19Mar 18Jun 17
# Analysts8157661210161571616121817
SG&A-------$149.17M$135.29M$100.87M$56.25M$74.57M$12.70M$7.27M$2.13M
Avg Forecast$958.05M$920.77M$713.86M$603.47M$90.64M$511.59M$431.47M$32.79M$22.13M$34.45M$74.92M$13.82M$22.68M$3.58M$3.40M
High Forecast$1.07B$1.01B$782.82M$661.77M$108.77M$522.94M$473.15M$39.35M$26.55M$41.34M$89.90M$16.58M$27.21M$4.30M$4.08M
Low Forecast$875.01M$861.10M$634.85M$536.68M$72.51M$466.46M$383.72M$26.23M$17.70M$27.56M$59.94M$11.05M$18.14M$2.87M$2.72M
Surprise %-------4.55%6.11%2.93%0.75%5.40%0.56%2.03%0.63%

argenx SE's average Quarter SG&A projection for Sep 23 is $431.47M, based on 10 Wall Street analysts, with a range of $383.72M to $473.15M. The forecast indicates a 189.24% rise compared to ARGX last annual SG&A of $149.17M (Mar 23).

argenx SE EPS Forecast

Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Mar 23Dec 22Mar 22Mar 21Sep 20Mar 19Mar 18Jun 17
# Analysts8157661210161571616121817
EPS-------$-0.52$-0.70$-4.36$-0.81$-3.16$0.20$-0.81$-0.01
Avg Forecast$1.75$1.13$0.09$-0.84$-0.72$-1.13$-1.32$1.31$1.78$1.29$-4.16$-1.30$-1.33$-0.19$-0.60
High Forecast$2.60$2.23$0.10$-0.72$-0.61$-0.59$-1.13$1.48$2.00$1.29$-3.33$-1.04$-1.06$-0.15$-0.47
Low Forecast$0.07$-0.04$0.08$-0.94$-0.81$-2.38$-1.49$1.12$1.52$1.29$-5.01$-1.56$-1.58$-0.23$-0.71
Surprise %--------0.40%-0.39%-3.38%0.19%2.43%-0.15%4.34%0.02%

According to 16 Wall Street analysts, argenx SE's projected average Quarter EPS for Sep 20 is $-1.30, with a low estimate of $-1.56 and a high estimate of $-1.04. This represents a -751.30% decrease compared to ARGX previous annual EPS of $0.20 (Mar 19).

argenx SE Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TERNTerns Pharmaceuticals$6.80$18.67174.56%Buy
LEGNLegend Biotech$34.68$89.60158.36%Buy
APLSApellis Pharmaceuticals$34.53$70.80105.04%Buy
AMLXAmylyx Pharmaceuticals$4.28$8.2592.76%Buy
DAWNDay One Biopharmaceuticals$12.64$24.0089.87%Buy
ZLABZai Lab$26.97$50.0085.39%Buy
PCVXVaxcyte$89.86$148.8065.59%Buy
AKROAkero Therapeutics$30.61$50.0063.35%Buy
ASNDAscendis Pharma$140.30$211.1450.49%Buy
BGNEBeiGene$179.06$267.3349.30%Buy
BPMCBlueprint Medicines$96.48$122.6027.07%Buy
TVTXTravere Therapeutics$17.14$21.7526.90%Buy
ALNYAlnylam Pharmaceuticals$246.58$310.6025.96%Buy
ARGXargenx SE$638.33$558.78-12.46%Buy

ARGX Forecast FAQ


Is argenx SE a good buy?

Yes, according to 21 Wall Street analysts, argenx SE (ARGX) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 18 'Buy' recommendations, accounting for 90.48% of ARGX's total ratings.

What is ARGX's price target?

argenx SE (ARGX) average price target is $558.78 with a range of $500 to $715, implying a -10.74% from its last price of $626.03. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will argenx SE stock go up soon?

According to Wall Street analysts' prediction for ARGX stock, the company can go down by -10.74% (from the last price of $626.03 to the average price target of $558.78), up by 14.21% based on the highest stock price target, and down by -20.13% based on the lowest stock price target.

Can argenx SE stock reach $900?

ARGX's average twelve months analyst stock price target of $558.78 does not support the claim that argenx SE can reach $900 in the near future.

What are argenx SE's analysts' financial forecasts?

argenx SE's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $661.8M (high $702.21M, low $594.36M), average EBITDA is $-705M (high $-613M, low $-776M), average net income is $-377M (high $-286M, low $-514M), average SG&A $975.84M (high $1.04B, low $876.4M), and average EPS is $-1.138 (high $-0.242, low $-2.749). ARGX's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.89B (high $2.08B, low $1.71B), average EBITDA is $-1.362B (high $-1.215B, low $-1.515B), average net income is $-179M (high $-57.168M, low $-304M), average SG&A $2.33B (high $2.56B, low $2.11B), and average EPS is $-0.332 (high $1, low $-1.712).

Did the ARGX's actual financial results beat the analysts' financial forecasts?

Based on argenx SE's last annual report (Dec 2022), the company's revenue was $410.75M, beating the average analysts forecast of $38.37M by 970.56%. Apple's EBITDA was $-693M, beating the average prediction of $-290M by 138.80%. The company's net income was $-710M, beating the average estimation of $-288M by 146.01%. Apple's SG&A was $472.13M, beating the average forecast of $56.57M by 734.54%. Lastly, the company's EPS was $-13.05, missing the average prediction of $3.07 by -525.65%. In terms of the last quarterly report (Mar 2023), argenx SE's revenue was $219.14M, beating the average analysts' forecast of $22.24M by 885.46%. The company's EBITDA was $-87.155M, missing the average prediction of $-218M by -59.95%. argenx SE's net income was $-28.871M, missing the average estimation of $-216M by -86.62%. The company's SG&A was $149.17M, beating the average forecast of $32.79M by 354.94%. Lastly, the company's EPS was $-0.52, missing the average prediction of $1.31 by -139.57%